Continuous Precision Medicine

About

Continuous Precision Medicine™ is a leader in the fight against the opioid epidemic.

We are engineering tools and services to combat one of the most costly and emotionally damaging issues in healthcare, opioid addiction.

Our Team

Steven Walther, MBA

Chief Executive Officer & Co-Founder

Steven, an inventor and successful entrepreneur, is medically trained and has over a decade of healthcare related experience. He attended Campbell University, earning a Master of Business Administration and John F. Kennedy Special Warfare Center & School, earning a Green Beret. Steven is especially driven in his work with CPM, as he fought against this very issue of opioid addiction while serving in Afghanistan.

Annmarie O'Donnell

Director of Technology

Annmarie is an accomplished leader of software development teams. She started her career with Fortune 500 company IBM, working her way through the technical ranks and then into middle management. She has managed teams of all sizes, from a handful of technically skilled individuals to large organizations of technical personnel, driving the delivery of enterprise applications and support platforms. She earned a B.S., Mathematical Sciences (Computer Science Emphasis) from the University of North Carolina at Chapel Hill.

Andrew Harvey

Lead Developer

Andrew is experienced in JavaScript and cloud computing within interests in pharmacodynamic analysis and data visualization. He studied Computer Science and Biology at UNC Chapel Hill with a focus on biological systems modeling and interface development. He currently serves as the team’s lead programmer and supervises development of the company’s web interfaces, smart phone apps, cloud infrastructure, and machine learning systems.

Jessica Kelley Morgan, PhD

Vice President of Research and Development

Dr. Morgan earned her Ph.D. at North Carolina State University in Applied Social and Community Psychology with concentrations in Health Psychology and Statistics and Methods. She has extensive research experience in the development, adaptation, and evaluation of behavioral health interventions, including substance misuse prevention programming and the use of mobile applications in behavioral health promotion. Dr. Morgan has collaborated on several novel and innovative methods for preventing substance use, including the use of mobile applications and online/web-based interventions for the Department of Defense and the National Institute on Drug Abuse.

Barry L. Jenkins, MD

Chairman of the Board & Founder

Dr. Jenkins received his medical degree from Harvard Medical School and completed post graduate training in Anesthesiology at the University of Pennsylvania. He practiced in his home town of Pottsville, Pennsylvania for 28 years as the Chairman of the Department of Anesthesiology and Pain Management of Pottsville Hospital, later Schuylkill Health. Dr. Jenkins also served as a clinical instructor for the University of Scranton Anesthesia post-graduate training program, where he taught practical clinical pharmacokinetic and pharmacodynamic methods of opioid narcotic management. He is a diplomat of the American Board of Anesthesiology.

Donald R. Gintzig, MBA

Board Member & Advisor

Mr. Gintzig is the Chief Executive Officer and President at WakeMed Health & Hospitals, Inc. He also served as Rear Admiral, Deputy Chief, Bureau of Medicine and Surgery, in the United States Navy and as Senior Vice President with UnitedHealth Group. Mr. Gintzig has over 25 years of experience as a senior healthcare executive. He is a member of the American College of Health Care Executives. Mr. Gintzig received his Bachelor’s and Master of Business Administration degrees from George Washington University, Washington, D. C.

Solomon Luo, MD

Board Member and Advisor

Internationally renowned ophthalmologist, Solomon C. Luo, MD, FACS, graduated with a Bachelor’s Degree in Biology from Fu-Fen Catholic University, Taiwan in 1973. Dr. Luo moved to the United States in 1975 and received his Master’s Degree from the University of Texas at Dallas in 1978 and his doctorate from the University of Texas Medical Branch at Galveston in 1982. He completed his ophthalmology residency at Temple University Hospital. Dr. Luo is a board-certified ophthalmologist specializing in cataract and refractive surgery and has lectured both nationally and internationally on both disciplines.

Robert Zimmerman, MD

Board Member & Advisor

Dr. Robert Zimmerman Jr, DO is an obstetrics & gynecology specialist in Pottsville, PA and has been practicing for 26 years. He graduated from Philadelphia College Of Osteopathic Medicine in 1988 and specializes in obstetrics & gynecology.

Jeff E. Mandel, MD

Advisor

Jeff E Mandel received his MD from University of Texas Health Sciences Center at San Antonio and his MS in Control Theory from the University of California, San Diego. Dr. Mandel has been active in research in the area of control of anesthesia delivery for over 30 years, has authored over 50 publications, and lectured around the world. He has been active in the Society for Technology in Anesthesia, and served as President in 2020.

Steve Charles

Advisor

Mr. Steve Charles Co-founded immixGroup, Inc. in 1997 and served as its Executive Vice President until it was acquired by Arrow Electronics in 2015. Mr. Charles now serves as a consultant to Arrow. He received a BA in Communications & Business, Magna Cum Laude from Temple University and has completed extensive coursework in government procurement at American University, George Washington University, University of Virginia and the National Contract Management Association.

News

The Postpartum Period as a Point of Prevention for Opioid Misuse: A Commentary

The nationwide increase in opioid use has led to an epidemic in the United States, resulting in an increase of opioid-related overdose deaths and opioid analgesic prescriptions over the last two decades. The risk of long-term opioid use post-surgery increases when patients are treated with opioid analgesics compared to their counterparts. Guidelines state that opioid analgesics are not always necessary and should be prescribed for the lowest effective dose only as long as pain is expected to be severe; however, over-prescription is common with general populations showing that half the amount of prescribed opioids do not get used by patients.

Evaluation of a Mobile Application to Decrease Opioid Misuse and Habit-Forming Behaviors Following Prescription: Preliminary Results and Future Directions

Opioid misuse can, and should, be characterized as an epidemic and public health crisis. Opioid misuse, use disorders, and overdoses are costly in terms of morbidity, mortality, and humanitarian and economic costs. Managing the use of opioids in the postoperative period is an essential point of intervention in combating the opioid crisis. To address this critical issue, Continuous Precision Medicine (CPM; Research Triangle Park, NC) has developed a mobile application that tracks a patient’s pain and usage of both opiates and non-steroidal anti-inflammatory (NSAID) medications to manage that pain.

Doctors And Dentists Still Flooding U.S. With Opioid Prescriptions

Doctors and other health care providers still prescribe highly addictive pain medications at rates widely considered unsafe. Critics say the practice exposes tens of millions of patients each year to unnecessary risk of addiction, overdose and death.

Forty-one N.C. counties classified as “high risk” in new opioid study

In a national study, researchers classified 41 North Carolina counties as “opioid high-risk” with few providers of medication-assisted treatment and many opioid-related deaths.

Opioid Overdose Prevention

The best ways to prevent opioid overdose deaths are to improve opioid prescribing, reduce exposure to opioids, prevent misuse, and treat opioid use disorder.

preventative care. definitive results.

About